# Commission Regulation (EU) No 985/2013 of 14 October 2013 amending and correcting Annex I to Regulation (EC) No 1334/2008 of the European Parliament and of the Council as regards certain flavouring substances (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

Part A of Annex I to Regulation (EC) No 1334/2008 is amended as follows:
(1) the entry concerning FL No 02.093 is replaced by the following:
‘
02.093
(Z)-Non-6-en-1-ol
35854-86-5
324
10294
JECFA
’
(2) the entry concerning FL No 02.110 is replaced by the following:
‘
02.110
2,6-Dimethylhept-6-en-1-ol
36806-46-9
348
At least 90 %; secondary component 5-10 % 2,6-dimethyl-5-hepten-1-ol
JECFA
’
(3) the entry concerning FL No 02.145 is replaced by the following:
‘
02.145
2,6-Dimethylocta-1,5,7-trien-3-ol
29414-56-0
EFSA
’
(4) the entry concerning FL No 02.194 is replaced by the following:
‘
02.194
Octa-1,5-dien-3-ol
83861-74-9
EFSA
’
(5) the entry concerning FL No 02.211 is replaced by the following:
‘
02.211
Undeca-1,5-dien-3-ol
56722-23-7
EFSA
’
(6) the entry concerning FL No 02.229 is replaced by the following:
‘
02.229
(-)-3,7-Dimethyl-6-octen-1-ol
7540-51-4
At least 90 % cis-isomer; secondary components 2-6 % di-unsaturated and saturated C10 alcohols, 2-4 % citronellyl acetate and 2-3 % citronellal
EFSA
’
(7) the entry concerning FL No 02.252 is replaced by the following:
‘
02.252
4,8-Dimethyl-3,7-nonadien-2-ol
67845-50-5
1841
EFSA
’
(8) the entry concerning FL No 05.026 is replaced by the following:
‘
05.026
o-Tolualdehyde
529-20-4
EFSA
’
(9) the entry concerning FL No 05.028 is replaced by the following:
‘
05.028
m-Tolualdehyde
620-23-5
EFSA
’
(10) the entry concerning FL No 05.029 is replaced by the following:
‘
05.029
p-Tolualdehyde
104-87-0
EFSA
’
(11) the entry concerning FL No 05.085 is replaced by the following:
‘
05.085
(Z)-Hept-4-enal
6728-31-0
320
2124
At least 93 % of Z-form of hept-4-enal; secondary component 2-5 % of E-form of hept-4-enal.
JECFA
’
(12) the entry concerning FL No 05.137 is replaced by the following:
‘
05.137
Dec-4(cis)-enal
21662-09-9
At least 90 %; secondary component at least 5 % trans-isomer
EFSA
’
(13) the entry concerning FL No 05.182 is replaced by the following:
‘
05.182
2,6,6-Trimethylcyclohex-2-ene-1-carboxaldehyde
432-24-6
EFSA
’
(14) the entry concerning FL No 07.190 is replaced by the following:
‘
07.190
Octa-1,5-dien-3-one
65213-86-7
1848
Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-form
EFSA
’
(15) the entry concerning FL No 07.198 is replaced by the following:
‘
07.198
Pseudo-ionone
141-10-6
11191
EFSA
’
(16) the entry concerning FL No 07.202 is replaced by the following:
‘
07.202
2,6,6-Trimethylcyclohex-2-en-1-one
20013-73-4
EFSA
’
(17) the entry concerning FL No 07.204 is replaced by the following:
‘
07.204
3,3,6-Trimethylhepta-1,5-dien-4-one
546-49-6
EFSA
’
(18) the entry concerning FL No 07.255 is replaced by the following:
‘
07.255
l-Piperitone
4573-50-6
1856
EFSA
’
(19) the entry concerning FL No 08.004 is replaced by the following:
‘
08.004
Lactic acid
50-21-5
930
4
EFSA
’
(20) the entry concerning FL No 09.016 is replaced by the following:
‘
09.016
Menthyl acetate
16409-45-3
431
206
JECFA
’
(21) the entry concerning FL No 09.131 is replaced by the following:
‘
09.131
DL-Isobornyl propionate
2756-56-1
1391
412
EFSA
’
(22) the entry concerning FL No 09.132 is replaced by the following:
‘
09.132
Benzyl propionate
122-63-4
842
413
EFSA
’
(23) the entry concerning FL No 09.266 is replaced by the following:
‘
09.266
Hexyl 2-butenoate
19089-92-0
1807
10688
EFSA
’
(24) the entry concerning FL No 09.562 is replaced by the following:
‘
09.562
trans-3-Hexenyl formate
56922-80-6
EFSA
’
(25) the entry concerning FL No 09.578 is replaced by the following:
‘
09.578
Hexyl (E)-but-2-enoate
1617-25-0
10688
EFSA
’
(26) the entry concerning FL No 09.596 is replaced by the following:
‘
09.596
Isopentyl-(Z)-but-2-enoate
10482-55-0
EFSA
’
(27) the entry concerning FL No 09.854 is replaced by the following:
‘
09.854
cis-3-Hexenyl 2-methylbutanoate
53398-85-9
EFSA
’
(28) the entry concerning FL No 09.858 is replaced by the following:
‘
09.858
Phenylmethyl 2-methyl-2-butenoate
67674-41-3
Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-form
EFSA
’
(29) the entry concerning FL No 09.880 is replaced by the following:
‘
09.880
(Z)-Hept-4-en-2-yl butanoate
94088-12-7
EFSA
’
(30) the entry concerning FL No 09.936 is replaced by the following:
‘
09.936
4,8-Dimethyl-3,7-nonadien-2-yl acetate
91418-25-6
1847
EFSA
’
(31) the entry concerning FL No 12.075 is replaced by the following:
‘
12.075
Methyl prop-1-enyl disulfide
5905-47-5
569
11712
At least 90 %; secondary components 3-4 % dimethyl disulfide and 3-4 % di-1-propenyl disulfide
JECFA
’
(32) the entry concerning FL No 12.086 is replaced by the following:
‘
12.086
S-Methyl 2-methylbutanethioate
42075-45-6
486
JECFA
’
(33) the entry concerning FL No 12.273 is replaced by the following:
‘
12.273
3-(Methylthio)heptanal
51755-70-5
1692
At least 92 %; secondary component 5-7 % (E)-hept-2-enal
EFSA
’
(34) the entry concerning FL No 13.028 is replaced by the following:
‘
13.028
2-Butyl-5 or 6-keto-1,4-dioxane
65504-95-2
1484
2206
EFSA
’
(35) the entry concerning FL No 13.170 is replaced by the following:
‘
13.170
2S-cis-Tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran
3033-23-6
EFSA
’
(36) the entry concerning FL No 13.190 is replaced by the following:
‘
13.190
3-((2-methyl-3-furyl)thio)-2-butanone
61295-44-1
1525
EFSA
’
(37) the entry concerning FL No 14.067 is replaced by the following:
‘
14.067
2-Ethoxy-3-methylpyrazine
32737-14-7
793
11921
At least 82 % 2-ethoxy-3-methylpyrazine. Secondary components 15 % 2–ethoxy-5-methylpyrazine (CAS no 67845-34-5) or 2-ethoxy-6-methylpyrazine (CAS no 53163-97-6)
EFSA
’
(38) the entry concerning FL No 15.134 is replaced by the following:
‘
15.134
2,5-Dihydroxy-1,4-dithiane
40018-26-6
550
Mixture of diastereoisomers: 25-30 % of (2S,5S and 2R,5R) and 70-75 % (2S,5R and 2R,5S)
EFSA
’
(39) the entry concerning FL No 16.095 is replaced by the following:
‘
16.095
Cyclopropanecarboxamide, N-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-
744251-93-2
1779
EFSA
’
(40) the entry concerning FL No 16.123 is replaced by the following:
‘
16.123
(1R,2S,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide
68489-09-8
EFSA
’
(41) the entry concerning FL No 17.015 is replaced by the following:
‘
17.015
DL-Methylmethioninesulphonium chloride
3493-12-7
1427
761
EFSA
’

---
Source: https://www.legislation.gov.uk/eur/2013/985/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2013-985/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.